{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:11Z","timestamp":1761559991362},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T00:00:00Z","timestamp":1300320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T00:00:00Z","timestamp":1300320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s12325-011-0003-7","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T13:29:55Z","timestamp":1300541395000},"page":"311-325","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Polyquad-preserved travoprost\/timolol, benzalkonium chloride (BAK)-preserved travoprost\/timolol, and latanoprost\/timolol in fixed combinations: a rabbit ocular surface study"],"prefix":"10.1007","volume":"28","author":[{"given":"Hong","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Brignole-Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Riancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,17]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1185\/030079907X233287","volume":"23","author":"J.K. Schmier","year":"2007","unstructured":"Schmier JK, Covert DW, Robin AL. Estimated firstyear costs of prostaglandin analogs with\/without adjunctive therapy for glaucoma management: a United States perspective. Curr Med Res Opin. 2007;23:2867\u20132875.","journal-title":"Curr Med Res Opin"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1185\/03007990902791132","volume":"25","author":"J.K. Schmier","year":"2009","unstructured":"Schmier JK, Covert DW, Robin AL. First-year treatment patterns among new initiators of topical prostaglandin analogs. Curr Med Res Opin. 2009;25:851\u2013858.","journal-title":"Curr Med Res Opin"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","volume":"144","author":"A.L. Robin","year":"2007","unstructured":"Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533\u2013540.","journal-title":"Am J Ophthalmol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/ICO.0b013e3181ae8402","volume":"28","author":"C. Baudouin","year":"2009","unstructured":"Baudouin C. The ocular surface in glaucoma. Cornea. 2009;28:S14\u2013S19.","journal-title":"Cornea"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C. Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312\u2013334.","journal-title":"Prog Retin Eye Res"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","volume":"106","author":"C. Baudouin","year":"1999","unstructured":"Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Ophthalmology. 1999;106:556\u2013563.","journal-title":"Ophthalmology"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"P.J. Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002;86:418\u2013423.","journal-title":"Br J Ophthalmol"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"E.W. Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17:350\u2013355.","journal-title":"J Glaucoma"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"R.D. Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29:618\u2013621.","journal-title":"Cornea"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/jop.2006.22.267","volume":"22","author":"A. Labbe","year":"2006","unstructured":"Labbe A, Pauly A, Liang H, et al. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther. 2006;22:267\u2013278.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12325-009-0023-8","volume":"26","author":"C. Lipener","year":"2009","unstructured":"Lipener C. A randomized clinical comparison of OPTI-FREE EXPRESS and ReNu MultiPLUS multipurpose lens care solutions. Adv Ther. 2009;26:435\u2013446.","journal-title":"Adv Ther"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.ophtha.2006.03.025","volume":"113","author":"J.T. Whitson","year":"2006","unstructured":"Whitson JT, Ochsner KI, Moster MR, et al. The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1. Ophthalmology. 2006;113:1333\u20131339.","journal-title":"Ophthalmology"},{"key":"3_CR13","unstructured":"Liang H, Brignole-Baudouin F, Riancho L, Baudouin C. In vivo assessment of the ocular surface effects of travoprost BAK-free versus BAKpreserved travoprost and latanoprost ophthalmic solutions. Paper presented at: Tear Film & Ocular Surface, Florence, Italy, September 22\u201325, 2010,."},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/02713689109013856","volume":"10","author":"D. Lopez Bernal","year":"1991","unstructured":"Lopez Bernal D, Ubels JL. Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives. Curr Eye Res. 1991;10:645\u2013656.","journal-title":"Curr Eye Res"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003226-199211030-00006","volume":"11","author":"H. Ichijima","year":"1992","unstructured":"Ichijima H, Petroll WM, Jester JV, Cavanagh HD. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea. 1992;11:221\u2013225.","journal-title":"Cornea"},{"key":"3_CR16","first-page":"1690","volume":"15","author":"H. Liang","year":"2009","unstructured":"Liang H, Baudouin C, Faure MO, Lambert G, Brignole-Baudouin F. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. Mol Vis. 2009;15:1690\u20131699.","journal-title":"Mol Vis"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","volume":"92","author":"H. Liang","year":"2008","unstructured":"Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol. 2008;92:1275\u20131282.","journal-title":"Br J Ophthalmol"},{"key":"3_CR18","first-page":"204","volume":"14","author":"H. Liang","year":"2008","unstructured":"Liang H, Brignole-Baudouin F, Rabinovich-Guilatt L, et al. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. Mol Vis. 2008;14:204\u2013216.","journal-title":"Mol Vis"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.exer.2003.08.005","volume":"78","author":"F. Brignole-Baudouin","year":"2004","unstructured":"Brignole-Baudouin F, Ott AC, Warnet JM, Baudouin C. Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res. 2004;78:473\u2013481.","journal-title":"Exp Eye Res"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.eye.6702058","volume":"20","author":"E.M. Haller-Schober","year":"2006","unstructured":"Haller-Schober EM, Schwantzer G, Berghold A, Fischl M, Theisl A, Horwath-Winter J. Evaluating an impression cytology grading system (IC score) in patients with dry eye syndrome. Eye. 2006;20:927\u2013933.","journal-title":"Eye"},{"key":"3_CR21","unstructured":"Brignole-Baudouin F, Riancho L, Liang H, Baudouin C. In vitro comparative toxicology of BAK-free and BAK-preserved travoprost\/timolol fixed combination and latanoprost\/timolol fixed concentration. J Ocul Pharmacol Ther. In press."},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","volume":"27","author":"D.A. Ammar","year":"2010","unstructured":"Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride-preserved, polyquadpreserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther. 2010;27:837\u2013845.","journal-title":"Adv Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-011-0003-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12325-011-0003-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:20:47Z","timestamp":1724412047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-011-0003-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,17]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s12325-011-0003-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2011,3,17]]},"assertion":[{"value":"17 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2011","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}